Supercharging a New FDA: Marty Makary on Science, Power & Patients

The conversation centers on modernizing the FDA, addressing competition with China, and reforming healthcare. Marty Makary, FDA Commissioner, details efforts to streamline drug approval processes, including reducing animal testing and transitioning to continuous trials using AI. He emphasizes prioritizing protein in diets, reversing the food pyramid, and increasing access to over-the-counter drugs to lower costs. Makary critiques the NIH's focus on genetic research, advocating for studies on environmental factors impacting conditions like autism. He highlights initiatives to enforce regulations on misleading pharmaceutical advertising and promote fair pricing, aiming to deliver faster cures and rebuild public trust in health institutions.